[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357288-105":59,"doc-detail-357288-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","association-of-hydrochlorothiazide-exposure-with-all-cause-mortality-among-us-cancer-survivors-a-prospective-cohort-study","Association of hydrochlorothiazide exposure with all-cause mortality among US cancer survivors - A prospective cohort study","","Hydrochlorothiazide (HCTZ) is commonly prescribed to cancer patients, yet evidence on how HCTZ exposure affects mortality risk among cancer survivors remains limited. A prospective cohort was built using NHANES data from 2003–2018 to evaluate associations between self-reported HCTZ exposure and all-cause mortality. Cox models assessed survival, and logistic regression examined cardiovascular and cerebrovascular disease risks. The final cohort included 4202 survivors with 1337 deaths over a mean 6.93-year follow-up, and HCTZ exposure was linked to lower all-cause mortality risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/association-of-hydrochlorothiazide-exposure-with-all-cause-mortality-among-us-cancer-survivors-a-prospective-cohort-study/357288/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/association-of-hydrochlorothiazide-exposure-with-all-cause-mortality-among-us-cancer-survivors-a-prospective-cohort-study/357288.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was HCTZ exposure defined in the study?","Question",{"text":112,"@type":113},"Participants were categorized into two groups based on their self-reported use of hydrochlorothiazide.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What statistical methods were used to evaluate mortality risk?",{"text":117,"@type":113},"Multivariate-adjusted Cox proportional hazards models were used to compare all-cause mortality between groups.",{"name":119,"@type":110,"acceptedAnswer":120},"What limitation affects interpretation of the study’s protective finding?",{"text":121,"@type":113},"HCTZ use was assessed only once by self-report, with no detailed information on dosage, duration, indication, cancer stage, or treatment regimens.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},357288,1790211783,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","®  \n Observational Study   \nAssociation of hydrochlorothiazide exposure with all-cause mortality among US cancer survivors A prospective cohort study  \nQiang Li, MSa , Zheng-Hong Xiao, BSb , Peng-Hao Wen, MSb , Xu Zhang, MSa , Ping Li, MSa , Yan-Hua Ding, MSa , Hong Yang, BSc , Tian-Cai Wang, BSd , Tian-Yu Li, MSc , Bo Zhao, MSe , Jiang-Xia Zhang, BSa ,*  \n\n| Abstract\u003Cbr>Hydrochlorothiazide (HCTZ) is commonly prescribed to cancer patients. However, there is a paucity of research examining the effects of HCTZ exposure on the mortality risk of cancer survivors. We constructed a prospective cohort using data from the National Health and Nutrition Examination Survey from 2003 to 2018 to investigate the associations between HCTZ exposure and the risk of all-cause mortality among cancer survivors. The participants were categorized into 2 groups based on their self-reported use of HCTZ. Multivariate-adjusted Cox proportional hazards models were used to assess the survival outcomes between groups. Multivariate-adjusted logistic regression models were conducted to investigate the association between HCTZ exposure and the risk of cardiovascular disease and cerebrovascular disease. The final cohort comprised 4202 cancer survivors, with a mean age (standard deviation) of 66.01 ± 14.35 years. Of these, 53.2% were females, and 68.4% were non-Hispanic White individuals. The medication stratification identified 3517 non-HCTZ-exposed individuals and 685 HCTZ-exposed individuals. During a mean follow-up of 6.93 years (maximum 17 years), 1337 deaths were recorded. Compared with non-HCTZ-exposed individuals, HCTZ-exposed individuals presented reduced risk of all-cause mortality (hazard ratio = 0.80, 95% confidence interval [CI] = 0.67–0.95; P = .003) . Cross-sectional studies have indicated that exposure to HCTZ is associated with a lower risk of angina pectoris (odds ratio = 0.81, 95% CI = 0.72–0.93; P \u003C .001) and heart attack (odds ratio = 0.89, 95% CI = 0.84–0.95; P = .001) . HCTZ exposure is likely correlated with a lower risk of all-cause mortality in cancer survivors. However, HCTZ use among participants was assessed only once via self-report, lacking detailed information on dosage, duration of use, indication, cancer stage, and treatment regimens, precluding definitive conclusions regarding a protective effect of HCTZ. Further research is warranted to confirm these findings. |\n| --- |\n| Abbreviations: BMI = body mass index, CI = confidence interval , HCTZ = hydrochlorothiazide, HR = hazard ratio, NHANES = National Health and Nutrition Examination Survey. |\n| Keywords: all-cause mortality, cancer survivors, hydrochlorothiazide, NHANES |\n\n1. Introduction  \nCancer remains one of the leading causes of death worldwide, imposing a substantial economic burden on global communities,[1,2] although recent advances in medical technologies have significantly extended the survival of cancer patients. [3–5] The management of comorbidities among this population has increasingly become a complex clinical challenge. [6–11] Hydrochlorothiazide (HCTZ) is a commonly used agent  \nfrequently prescribed to cancer survivors for comorbidity management. [12–14] Inappropriate use of such medications may lead to severe adverse outcomes, including death.[15,16] Notably, accumulating evidence presents conflicting perspectives on HCTZ’s effects among cancer patients. Several studies have reported associations between HCTZ use and elevated risks of keratinocyte carcinoma and melanoma,[17–19] while numerous investigations suggest that HCTZ may confer cardiovascular benefits, reduce proteinuria, and thereby improve patient prognosis. [20,21]  \nThe authors have no funding and conflicts of interest to declare. The datasets generated during and/or analyzed during the current study are publicly available.  \nThe National Health and Nutrition Examination Survey is a publicly accessible database approved by the US National Center for Health Statistics Institutional Review Board (","cbCaioYNgXQfRGAI","https://ap.wps.com/l/cbCaioYNgXQfRGAI","pdf",816119,"English","# Introduction\n## Study rationale and background\n# Abstract\n## Methods and outcomes","[{\"question\":\"How was HCTZ exposure defined in the study?\",\"answer\":\"Participants were categorized into two groups based on their self-reported use of hydrochlorothiazide.\"},{\"question\":\"What statistical methods were used to evaluate mortality risk?\",\"answer\":\"Multivariate-adjusted Cox proportional hazards models were used to compare all-cause mortality between groups.\"},{\"question\":\"What limitation affects interpretation of the study’s protective finding?\",\"answer\":\"HCTZ use was assessed only once by self-report, with no detailed information on dosage, duration, indication, cancer stage, or treatment regimens.\"}]","Association of hydrochlorothiazide exposure with all-cause mortality among US cancer survivors - A prospective cohort study | PDF",1790129546,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f4612842276a121f58473c91c897aa6.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dde3b635a627152377a6d966ce93059.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c453f2573634af9d4e7f83e236d697cd.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e4e922be6eaea96cdce41f78ab75774.webp",980,1306]